- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT06872255
Per-oral Endoscopic Myotomy (POEM) in Patients With Postfundplication Dysphagia (VADYSMA)
A Prospective Pilot Trial of Per-oral Endoscopic Myotomy (POEM) in Patients With Postfundplication Dysphagia (VADYSMA Trial)
Laparoscopic fundoplication represents the standard antireflux procedure, when conservative measures fail. However, any type of fundoplication may be accompanied by adverse events. Postfundoplication dysphagia (PFD) may hamper results of anti-reflux surgery. Endoscopic pneumatic dilation has been considered as the first line treatment option for persistent PFD. However, studies have not confirmed its effectiveness in this indication. Peroral endoscopic myotomy (POEM) became a standard treatment for the management of esophageal achalasia and moreover has also been assessed in a small cohort of patients with refractory PFD and some patients achieved significant treatment success. The investigators plan to perform a prospective international cohort multicenter study assessing the efficacy of POEM in patients with persistent and severe PFD.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Jan Martínek, prof., MD
- Telefonnummer: +420 723 708 839
- E-post: jan.martinek@fnusa.cz
Studer Kontakt Backup
- Navn: Martin Vašátko, MD
- Telefonnummer: +420 739 476 451
- E-post: martin.vasatko@fnusa.cz
Studiesteder
-
-
-
Trnava, Slovakia, 91701
- Har ikke rekruttert ennå
- University Hospital Trnava
-
Ta kontakt med:
- Rastislav Husťak, MD
- Telefonnummer: +421 33/593 81 11
- E-post: rhustak@gmail.com
-
Ta kontakt med:
- Ján Ušák, MD
- Telefonnummer: +421 33/593 81 11
- E-post: jan.usak@gmail.com
-
-
Slovakia
-
Martin, Slovakia, Slovakia, 03601
- Rekruttering
- Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava and University Hospital Martin,
-
Ta kontakt med:
- Martin Duricek, Ass. Prof
- Telefonnummer: +421 4203 973
- E-post: martin.duricek@gmail.com
-
Ta kontakt med:
- Peter Banovcin, Ass. Profesor
- Telefonnummer: +421 4203 448
- E-post: pbanovcin@gmail.com
-
-
-
-
-
Brno, Tsjekkia, 60200
- Rekruttering
- St. Anne's University Hospital Brno, Czech Republic
-
Ta kontakt med:
- Jan Martínek, prof., MD
- Telefonnummer: +420 723 708 839
- E-post: jan.martinek@fnusa.cz
-
Ta kontakt med:
- Martin Vašátko, MD
- Telefonnummer: +420 739 476 451
- E-post: martin.vasatko@fnusa.cz
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Patients after laparoscopic fundoplication procedure by Nissen (total, 360°), Dor (anterior, 180°) or Toupet (posterior, 270°) for gastroesophageal reflux disease no later than 10 years before enrolment.
- Refractory (> 6 months) and severe dysphagia after fundoplication procedure defined as an Eckardt score ≥3 and Mellow - Pinkas score ≥2 at baseline.
- X-ray (contrasted radiographic examination of the esophagus) characterized by both: a.) tapered narrowing of the distal esophagus and GEJ; b.) partial/total stagnation of the contrast solution above the GEJ
- Endoluminal planimetry: EGJ-DI < 3 mm2/mmHg (with 40ml)
- Age above 18 years
- Signed informed consent form
Exclusion Criteria:
- No previous attempt with at least one prokinetic drug
- Previous esophageal myotomy (open, laparoscopic or endoscopic)
- Primary esophageal motility disorder (achalasia etc.)
- Active erosive esophagitis
- Active peptic ulcer disease
- Esophageal stricture (peptic, malignant, other)
- Partial or complete supradiaphragmatic migration of the wrap and/or stomach (Hinder Type III - IV), Large hiatal hernia more than 5 cm
- Known eosinophilic esophagitis
- Severe coagulopathy
- Esophageal or gastric varices
- Advanced liver cirrhosis (Child B or Child C)
- Pregnancy or puerperium
- Malignant or pre-malignant esophageal diseases (dysplasia): patients with a history of such disease after its cure are eligible for enrolment
- Any other condition, which in the opinion of the investigator would interfere with study requirements
- Known gastroparesis
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: POEM arm
Patients, who will undergo peroral endoscopic myotomy for postfundoplication dysphagia |
All procedures will be performed by an experienced endoscopist, with a sufficient experience in "third space" endoscopy (at least 100 POEMs) under general anesthesia (internal preoperative examination is necessary) with a high-definition endoscope, fitted with a plastic distal attachment. Before the procedure, the patients will be administered intravenous antibiotics. Exclusively CO2 will be used for insufflation. POEM will be performed in a similar way as in patients with achalasia - the procedure consists of 4 steps: (1) mucosal incision and tunnel entry, (2) submucosal tunneling, (3) myotomy, and (4) closure of the mucosal entry with endoscopic clips or other closure devices. Perioperative protocol might differ according the usual way of performing POEM in a given center. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Efficacy POEM in patients with postfundoplication dysfagia
Tidsramme: 6 months
|
The primary outcome will be proportion of patients with treatment success defined as Eckardt score ≤ 2 and its decrease by at least 1 point after POEM at 6 months |
6 months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Eckardt score
Tidsramme: At baseline, 3, 6 and 12 months
|
The Eckardt score is the grading system used for the evaluation of severity of symptoms in patients with esophageal achalasia. Four symptoms are assessed (dysphagia, regurgitation, chest pain and weight loss) and their severity ranges from 0 (no symptom) to 3 (with every meal). Total score is their sum and ranges from 0 to 12 |
At baseline, 3, 6 and 12 months
|
|
Mellow - Pinkas score
Tidsramme: At baseline, 3, 6 and 12 months
|
The Mellow - Pinkas score is used to assess dysphagia grade before and after the interventions. Total score ranges from 0 to 3 (0 = able to eat normal diet, 1 = able to swallow some solid foods, 2 = able to swallow only semi solid foods, 3 = able to swallow liquids only) |
At baseline, 3, 6 and 12 months
|
|
PAGI-QOL score (Patient Assessment of Upper Gastrointestinal Disorders-Quality of Life)
Tidsramme: At baseline, 3, 6 and 12 months
|
The PAGI-QoL questionnaire contains of 30 items with five subscales: (1) daily activities; (2) clothing; (3) diet/food habits; (4) relationship; and (5) psychological well-being and distress. Each item is scored on a 6-point Likert scale, with response options ranging from 0 (none) to 5 (severe problem all of the time). Subscale scores are calculated by averaging the item responses. A total score is calculated by averaging subscale scores. Higher score means impairment in quality of life. |
At baseline, 3, 6 and 12 months
|
|
GERD-RHQL score (Gastroesophageal Reflux Disease Health-related Quality of Life)
Tidsramme: At baseline, 3, 6 and 12 months
|
The GERD-HRQL questionnaire was developed and validated to measure changes of typical GERD symptoms such as heartburn and regurgitation in response to surgical or medical treatment. Higher (greater) possible score means worst symptoms - ranging from 0 to 75. |
At baseline, 3, 6 and 12 months
|
|
Integrated Relaxation Pressure (IRP)
Tidsramme: At baseline, at 6 months
|
High resolution manometry - Median IRP recorded from 10 supine swallows, measured in mmHg. A value >15 mmHg indicates EGJ outflow obstruction. |
At baseline, at 6 months
|
|
Endoluminal planimetry (Endoflip)
Tidsramme: At baseline, ať 6 months
|
Pyloric distensibility measured by impedance planimetry (EndoFLIP device) |
At baseline, ať 6 months
|
|
Esophagogram
Tidsramme: At baseline, at 6 months
|
Esophagogram provides valuable information of the fundoplication, better appreciate a paraesophageal hernia and information on esophageal emptying. Patients will be advised overnight fasting prior to timed barium esophagogram. A contrast agent (e.g. barium, usually 100 to 250 mL) is ingested orally within 15-20 seconds. Left posterior oblique X-ray will be taken 2 and 5 minutes after contrast agent ingestion. Maximum esophageal width and column hights will be recorded at 2 and 5 minutes. |
At baseline, at 6 months
|
|
Eckardt score
Tidsramme: At baseline, 3 and 12 months
|
The Eckardt score is used to assess the severity of achalasia symptoms. It is based on the four main symptoms of achalasia: dysphagia, regurgitation, chest pain and weight loss. Each symptom has four levels of severity: none = 0 point, occasional = 1 point, daily = 2 points, each meal = 3 points. The sum of the points gives the final score. Final score scale: 0 (best) - 12 (worst). Treatment success is defined as a decrease of Eckardt score by at least 1 point and an overall Eckardt score ≤ 2. |
At baseline, 3 and 12 months
|
|
GERD
Tidsramme: At baseline, 3, 6 and 12 months
|
Presence of reflux esophagitis based on endoscopy findings. |
At baseline, 3, 6 and 12 months
|
|
Esophageal 24h-Hour pH metry
Tidsramme: At 3 months after procedure
|
An esophageal pH test measures how often stomach acid enters to the esophagus. It also measures how long the acid stays there. The test involves placing a catheter into the esophagus. The catheter or device will measure an acid level (known as pH level) for 24 hours. Post-POEM Esophageal acid exposure (DeMeester score, proportion of time with pH below 4)After |
At 3 months after procedure
|
|
PPI/H2 antagonists
Tidsramme: At baseline, 3, 6 and 12 months
|
PPI's and/or H2 antagonists use before and after procedure (POEM). |
At baseline, 3, 6 and 12 months
|
Samarbeidspartnere og etterforskere
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- VADYSMA
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .